| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea—a randomized controlled study
|
Enblom, A.
|
|
|
23 |
5 |
p. 1353-1361
|
artikel
|
| 2 |
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis
|
Cortes, J.
|
|
|
23 |
5 |
p. 1130-1137
|
artikel
|
| 3 |
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study
|
Vici, P.
|
|
|
23 |
5 |
p. 1121-1129
|
artikel
|
| 4 |
A multicenter randomized phase III trial of vinorelbine/gemcitabine doublet versus capecitabine monotherapy in anthracycline- and taxane-pretreated women with metastatic breast cancer
|
Pallis, A.G.
|
|
|
23 |
5 |
p. 1164-1169
|
artikel
|
| 5 |
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
|
Crea, F.
|
|
|
23 |
5 |
p. 1207-1213
|
artikel
|
| 6 |
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
|
Stebbing, J.
|
|
|
23 |
5 |
p. 1314-1319
|
artikel
|
| 7 |
A nonrandom association of gastrointestinal stromal tumor (GIST) and desmoid tumor (deep fibromatosis): case series of 28 patients
|
Dumont, A.G.
|
|
|
23 |
5 |
p. 1335-1340
|
artikel
|
| 8 |
A phase I dose escalation study of AT9283, a small molecule inhibitor of aurora kinases, in patients with advanced solid malignancies
|
Arkenau, H.-T.
|
|
|
23 |
5 |
p. 1307-1313
|
artikel
|
| 9 |
A phase II study of concurrent cetuximab–cisplatin and intensity-modulated radiotherapy in locoregionally advanced nasopharyngeal carcinoma
|
Ma, B.B.Y.
|
|
|
23 |
5 |
p. 1287-1292
|
artikel
|
| 10 |
Attributable causes of cancer in Japan in 2005—systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan
|
Inoue, M.
|
|
|
23 |
5 |
p. 1362-1369
|
artikel
|
| 11 |
Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy
|
Twelves, C.
|
|
|
23 |
5 |
p. 1190-1197
|
artikel
|
| 12 |
Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial
|
Gladieff, L.
|
|
|
23 |
5 |
p. 1185-1189
|
artikel
|
| 13 |
Cationic liposomal paclitaxel plus gemcitabine or gemcitabine alone in patients with advanced pancreatic cancer: a randomized controlled phase II trial
|
Löhr, J.M.
|
|
|
23 |
5 |
p. 1214-1222
|
artikel
|
| 14 |
Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial
|
Zhang, R.X.
|
|
|
23 |
5 |
p. 1348-1353
|
artikel
|
| 15 |
Changes in incidence, survival and mortality of prostate cancer in Europe and the United States in the PSA era: additional diagnoses and avoided deaths
|
Neppl-Huber, C.
|
|
|
23 |
5 |
p. 1325-1334
|
artikel
|
| 16 |
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy
|
Giordano, A.
|
|
|
23 |
5 |
p. 1144-1150
|
artikel
|
| 17 |
Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma
|
Alvarez, R.
|
|
|
23 |
5 |
p. 1274-1279
|
artikel
|
| 18 |
CNS disease in younger patients with aggressive B-cell lymphoma: an analysis of patients treated on the Mabthera International Trial and trials of the German High-Grade Non-Hodgkin Lymphoma Study Group
|
Schmitz, N.
|
|
|
23 |
5 |
p. 1267-1273
|
artikel
|
| 19 |
Cost comparison of axillary sentinel lymph node detection and axillary lymphadenectomy in early breast cancer. A national study based on a prospective multi-institutional series of 985 patients ‘on behalf of the Group of Surgeons from the French Unicancer Federation’
|
Classe, J.M.
|
|
|
23 |
5 |
p. 1170-1177
|
artikel
|
| 20 |
DNA ploidy in endometrial cancer: unfinished business?
|
Terada, K.
|
|
|
23 |
5 |
p. 1083-1084
|
artikel
|
| 21 |
Editorial board
|
|
|
|
23 |
5 |
p. ii-iii
|
artikel
|
| 22 |
Esophageal carcinoma advances in treatment results for locally advanced disease: review
|
Herskovic, A.
|
|
|
23 |
5 |
p. 1095-1103
|
artikel
|
| 23 |
EZH2 polymorphism and benefit from bevacizumab in colorectal cancer: another piece to the puzzle
|
Fornaro, L.
|
|
|
23 |
5 |
p. 1370-1371
|
artikel
|
| 24 |
Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project
|
González, C.A.
|
|
|
23 |
5 |
p. 1320-1324
|
artikel
|
| 25 |
HER2-negative (1+) breast cancer with unfavorable prognostic features: to FISH or not to FISH?
|
Iorfida, M.
|
|
|
23 |
5 |
p. 1371-1372
|
artikel
|
| 26 |
High prevalence of vertebral fractures in women with breast cancer starting aromatase inhibitor therapy
|
Bouvard, B.
|
|
|
23 |
5 |
p. 1151-1156
|
artikel
|
| 27 |
Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases
|
Saad, F.
|
|
|
23 |
5 |
p. 1341-1347
|
artikel
|
| 28 |
Minimising critical organ irradiation in limited stage Hodgkin lymphoma: a dosimetric study of the benefit of involved node radiotherapy
|
Campbell, B.A.
|
|
|
23 |
5 |
p. 1259-1266
|
artikel
|
| 29 |
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer
|
Michaelson, M.D.
|
|
|
23 |
5 |
p. 1234-1240
|
artikel
|
| 30 |
Multidisciplinary team working across different tumour types: analysis of a national survey
|
Lamb, B.W.
|
|
|
23 |
5 |
p. 1293-1300
|
artikel
|
| 31 |
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer
|
Rojo, F.
|
|
|
23 |
5 |
p. 1156-1164
|
artikel
|
| 32 |
Optimal prostate-specific antigen screening interval for prostate cancer
|
Kobayashi, D.
|
|
|
23 |
5 |
p. 1250-1253
|
artikel
|
| 33 |
Phase II study of eribulin mesylate (E7389) in patients with metastatic castration-resistant prostate cancer stratified by prior taxane therapy
|
de Bono, J.S.
|
|
|
23 |
5 |
p. 1241-1249
|
artikel
|
| 34 |
Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts
|
Reck, M.
|
|
|
23 |
5 |
p. 1111-1120
|
artikel
|
| 35 |
Preferences for cancer treatments: an overview of methods and applications in oncology
|
Blinman, P.
|
|
|
23 |
5 |
p. 1104-1110
|
artikel
|
| 36 |
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial
|
Ejlertsen, B.
|
|
|
23 |
5 |
p. 1138-1144
|
artikel
|
| 37 |
Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
|
Pradhan, M.
|
|
|
23 |
5 |
p. 1178-1184
|
artikel
|
| 38 |
Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer
|
Huh, J.W.
|
|
|
23 |
5 |
p. 1198-1206
|
artikel
|
| 39 |
Recent developments in treatments targeting castration-resistant prostate cancer bone metastases
|
Loriot, Y.
|
|
|
23 |
5 |
p. 1085-1094
|
artikel
|
| 40 |
Sequential research-related biopsies in phase I trials: acceptance, feasibility and safety
|
Gomez-Roca, C.A.
|
|
|
23 |
5 |
p. 1301-1306
|
artikel
|
| 41 |
Table of Contents
|
|
|
|
23 |
5 |
p. iv-vi
|
artikel
|
| 42 |
The eligibility of advanced non-small-cell lung cancer patients for targeted therapy clinical trials
|
Clarey, J.
|
|
|
23 |
5 |
p. 1229-1233
|
artikel
|
| 43 |
Third CECOG consensus on the systemic treatment of non-small-cell lung cancer
|
Brodowicz, T.
|
|
|
23 |
5 |
p. 1223-1229
|
artikel
|
| 44 |
Two escalated followed by six standard BEACOPP in advanced-stage high-risk classical Hodgkin lymphoma: high cure rates but increased risk of aseptic osteonecrosis
|
Fosså, A.
|
|
|
23 |
5 |
p. 1254-1259
|
artikel
|
| 45 |
Two sides of the medallion: poor treatment tolerance but better survival by standard chemotherapy in elderly patients with advanced-stage diffuse large B-cell lymphoma
|
van de Schans, S.A.M.
|
|
|
23 |
5 |
p. 1280-1286
|
artikel
|
Tijdschrift beschrijving